| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on December 17, 2004
Accepted on September 9, 2005
From the Molecular Cardiology Research Institute and Department of Medicine (X.Y., D.C, K.S., D.B.), Tufts-New England Medical Center, Boston, and the Division of Infectious Diseases and Immunology (D.T.G.), University of Massachusetts Medical School, Worcester, Mass.
* To whom correspondence should be addressed. E-mail: Dbeasley{at}tufts-nemc.org.
Objective--The intracellular bacterium Chlamydia pneumoniae is present in many atherosclerotic lesions, where it could promote inflammation. This study determined whether monocyte chemoattractant protein 1 (MCP-1) release is stimulated in vascular smooth muscle cells (VSMCs) that are exposed to or infected by C pneumoniae and whether toll-like receptor 2 (TLR2) or TLR4 mediate these effects.
Methods and Results--TLR2 mRNA was expressed constitutively and was upregulated by C pneumoniae exposure in mouse aortic SMC and was inducible by C pneumoniae and TLR3 and TLR4 agonists in human coronary artery SMCs. Exposure to inactivated or viable extracellular C pneumoniae evoked a robust increase in MCP-1 release and activated nuclear factor-
B and extracellular signal-regulated kinase 1/2 in wild-type and TLR4 signaling-deficient mouse aortic SMCs but not in TLR2-deficient SMCs, probably because of TLR2-mediated recognition of a chlamydial antigen. Brief exposure to viable C pneumoniae led to active infection of VSMCs, shown by chlamydial protein synthesis, and caused a persistent (>48-hour) MCP-1 release that was also TLR2 dependent.
Conclusions--The results show that VSMCs express functional TLR2 and that TLR2 mediates both a persistent activation of chemokine release in C pneumoniae-infected VSMCs and its acute stimulation by extracellular C pneumoniae. Therefore, TLR2 expressed in VSMCs may promote inflammation within the arterial wall.
B
extracellular signal-regulated kinase 1/2
heat shock protein 60
lipopolysaccharide
This article has been cited by other articles:
![]() |
H. Loppnow, K. Werdan, and M. Buerke Invited review: Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms Innate Immunity, April 1, 2008; 14(2): 63 - 87. [Abstract] [PDF] |
||||
![]() |
B. Petersen, K. D. Bloch, F. Ichinose, H.-S. Shin, M. Shigematsu, A. Bagchi, W. M. Zapol, and J. Hellman Activation of Toll-like receptor 2 impairs hypoxic pulmonary vasoconstriction in mice Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L300 - L308. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ehrentraut, S. Frede, H. Stapel, T. Mengden, C. Grohe, J. Fandrey, R. Meyer, and G. Baumgarten Antagonism of Lipopolysaccharide-Induced Blood Pressure Attenuation and Vascular Contractility Arterioscler. Thromb. Vasc. Biol., October 1, 2007; 27(10): 2170 - 2176. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Wang, F. Burczynski, J. Anderson, and G. Zhong Effect of host fatty acid-binding protein and fatty acid uptake on growth of Chlamydia trachomatis L2 Microbiology, June 1, 2007; 153(6): 1935 - 1939. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Schultz, V. Murthy, J. B. Tatro, and D. Beasley Endogenous interleukin-1{alpha} promotes a proliferative and proinflammatory phenotype in human vascular smooth muscle cells Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2927 - H2934. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Yang, V. Murthy, K. Schultz, J. B. Tatro, K. A. Fitzgerald, and D. Beasley Toll-like receptor 3 signaling evokes a proinflammatory and proliferative phenotype in human vascular smooth muscle cells Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2334 - H2343. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |